SPL 0.00% 10.5¢ starpharma holdings limited

Ann: Viraleze shows antiviral efficacy in COVID-19 patients, page-62

  1. 3,318 Posts.
    lightbulb Created with Sketch. 780
    ‘The statistical significance for the cohort under 45 IMO was met before end of trial for most in that cohort’ ~ @bid

    This is the most ludicrous re-engineering of an alternate reality I have ever read.

 
watchlist Created with Sketch. Add SPL (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.